1. [A patient with long-term, unrecognized leishmaniasis].
- Author
-
Rabelink NM, de Steenwinkel JE, van Biezen P, van Daele PL, and Gyssens IC
- Subjects
- Animals, Diagnosis, Differential, Humans, Leishmania braziliensis genetics, Leishmania braziliensis isolation & purification, Leishmaniasis, Mucocutaneous drug therapy, Leishmaniasis, Mucocutaneous surgery, Male, Middle Aged, Polymerase Chain Reaction methods, Sensitivity and Specificity, Treatment Outcome, Antiprotozoal Agents therapeutic use, DNA, Protozoan analysis, Leishmania braziliensis pathogenicity, Leishmaniasis, Mucocutaneous diagnosis
- Abstract
A man from Surinam presented at the Department of Internal Medicine with a perforated septum and progressive collapse of the nose. This condition had existed for 22 years, though earlier analysis had not revealed the cause. Microscopic analysis showed a granulomatous inflammatory reaction, with cultures revealing of Leishmania. The diagnosis was mucocutaneous leishmaniasis and PCR indicated Leishmania braziliensis complex. The patient was treated for mucocutaneous leishmaniasis by a 28-day course of intravenous sodium-stibogluconate therapy. Initially, treatment was stopped briefly due to neurotoxicity, but was recommenced and successfully completed. After treatment the infection parameters returned to normal and the patient was referred for reconstructive nasal surgery. Due to a low parasitic load mucocutaneous leishmaniasis can be difficult to detect, especially in chronic cases. However, the use of molecular techniques has improved both the sensitivity and specificity of detection. The ability to distinguish between different species and sub-species is of prognostic and therapeutic relevance.
- Published
- 2006